Biotech / Pharma
ArisGlobal
Biotech / Pharma
[subscription] Nordic Capital agreed to sell ArisGlobal, a developer of drug trial software, to Dassault Systemes for $2 billion.. ArisGlobal. Fwd: Francisco's $21B bet on slow-motion AI
Founded
Region
Investors
People